Newer multiple sclerosis drugs and disability scores - Are key data analyses missing?

Jagannadha R. Avasarala

doi:10.1002/jcph.535

Newer multiple sclerosis drugs and disability scores - Are key data analyses missing?

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	1218-1220
Number of pages	3
Journal	Journal of Clinical Pharmacology
Volume	55
Issue number	11
DOIs	https://doi.org/10.1002/jcph.535
State	Published - Nov 1 2015

Keywords

African American MS, disability metrics
expanded disability status scores (EDSS)
immune-modulating drugs
multiple sclerosis (MS)
no evidence of disease activity (NEDA)

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1002/jcph.535

Cite this

@article{161d11e76d7841df928ded753cf71943,

title = "Newer multiple sclerosis drugs and disability scores - Are key data analyses missing?",

keywords = "African American MS, disability metrics, expanded disability status scores (EDSS), immune-modulating drugs, multiple sclerosis (MS), no evidence of disease activity (NEDA)",

author = "Avasarala, \{Jagannadha R.\}",

year = "2015",

month = nov,

day = "1",

doi = "10.1002/jcph.535",

language = "English",

volume = "55",